Request Deal Involvement

Melinta Therapeutics terminated the $57m acquisition of Tetraphase Pharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Janney Montgomery Scott

financial advisors

Janney Montgomery Scott

Argot Partners

pr advisors

Argot Partners

WilmerHale

legal advisors

WilmerHale

or

Principals

TETRAPHASE PHARMACEUTICALS

target

TETRAPHASE PHARMACEUTICALS

MELINTA THERAPEUTICS

bidder

MELINTA THERAPEUTICS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Melinta Therapeutics terminated the $57m acquisition of Tetraphase Pharmaceuticals.